Drugs / Glucion
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02822898 Comparator | Jun → Aug 2016 | — | University Hospital, Antwerp | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Glucion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02822898 ↗ |
| Known as | Glucion 5% | “Glucion 5% (premixed solution containing 54 mmol/L sodium and 26 mmol/L potassium amongst others), administered at 25 mL/kg IBW/h for 48h” NCT02822898 ↗ |